Study of Chidamide, Decitabine and Immune Checkpoint Inhibitors in R/R NHL and Advanced Solid Tumors

NCT05320640 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Relapsed/Refractory Non-Hodgkin Lymphoma
Advanced Solid Tumors

Interventions

DRUG: Chidamide
DRUG: Decitabine
DRUG: Immune checkpoint inhibitors（anti-PD1/PD-L1/CTLA4 antibodies）

Sponsor

Chinese PLA General Hospital